Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment
Kyle Nolla, David J. Benjamin, David Cella
Topics & Concepts
MedicineSunitinibNivolumabRenal cell carcinomaClinical trialAtezolizumabIpilimumabCabozantinibInternal medicineOncologyKidney cancerPembrolizumabBevacizumabQuality of life (healthcare)ImmunotherapyLenvatinibCancerChemotherapyNursingThyroid cancerRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersEconomic and Financial Impacts of Cancer